Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 Mutations
Conditions: Cholangiocarcinoma; Chondrosarcoma; Glioma; Any Solid Tumor Intervention: Drug: LY3410738 Sponsors: Loxo Oncology, Inc.; Eli Lilly and Company Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bile Duct Cancer | Brain Tumor | Cancer & Oncology | Cholangiocarcinoma | Chondrosarcoma | Glioma | Research | Study